Skip to main content
From the Literature
New Data Reveal Mismatched Need and Supply of Oncology Physicians and Pharmacists in America
Read More
Case Reports, Acute Lymphoblastic Leukemia, Leukemia, Adverse Events
Pegaspargase-Induced Diabetic Ketoacidosis in a Patient with Acute Lymphoblastic Leukemia
Ellen Madarang, PharmD, BCOP, Leslie Gallardo, PharmD, BCPS, Terrence Bradley, MD
Ellen Madarang, PharmD, BCOP; Leslie Gallardo, PharmD, BCPS; Terrence Bradley, MD
Read More
HOPA Highlights
The Impact of Racial Disparities in Cancer Care: Racism a Risk Factor for Poor Clinical Outcomes
Read More
HOPA Highlights
Eliminating Structural Racism in Oncology Pharmacy: Individual and Organizational Responsibility
Read More
HOPA Highlights
New Opportunities for Pharmacists in Clinical Trials and Drug Development After COVID-19
Read More
HOPA Highlights
Immunotherapy Continues to Transform the Treatment Landscape for Advanced Non–Small-Cell Lung Cancer
Read More
HOPA Highlights
Cancer Pain Management and the Opioid Conundrum: Optimizing Outcomes, Minimizing Risks
Read More
HOPA Highlights
Managing Thromboembolism in Patients with Cancer: Which Are the Preferred Anticoagulants?
Read More
FDA Updates
Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation
Read More
FDA Updates
Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations
Read More
Page 90 of 199
Results 891 - 900 of 1986